Long acting beta adrenoceptor agonist: Difference between revisions
Jump to navigation
Jump to search
m Protected "Long acting beta adrenoceptor agonist": Robot: Protecting all pages from category Drug ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 15: | Line 15: | ||
{{Asthma and copd rx}} | {{Asthma and copd rx}} | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 17:00, 9 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
They are designed to replace the shorter acting B2-agonists such as salbutamol, as they have a duration of action of approximately 12 hours in comparison with the 4-6 hour duration of salbutamol, making them ideal candidates for twice-daily administration.
Indication
Long acting beta-adrenoceptor agonists are usually prescribed for moderate to severe persistent asthma patients or patients with COPD.
Types
Some long acting beta-adrenoceptor agonists are: